Consensus Valerio Therapeutics BOERSE MUENCHEN

Equities

C4X

FR0010095596

Market Closed - BOERSE MUENCHEN Other stock markets 20:43:40 05/06/2024 BST			5-day change	1st Jan Change
0.125 ^EUR	-2.50%		+25.93%	-15.38%

05-22	Valerio Therapeutics S.A. Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial	CI
04-30	Valerio Therapeutics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Evolution of the average Target Price on Valerio Therapeutics

Price target over the last 5 years

History of analyst recommendation changes

0837b37104476448afa80d3c319b70._aS2GWRscZoDLDkuONC1DnNi4YKSIEW1JfALa35pZ94.keDjTyIPPaliR1pLW7XhRSYx0bHdaD_vCN1tAQ04VuaextF0Pjsh23lUdA~688a468533108b4d4f85379314774c26

Analyst Recommendations on Valerio Therapeutics

Onxeo : Bryan Garnier & Co initiates the coverage of Onxeo with a “Buy” recommendation	29/05/20	PU
Bryan Garnier & Co Initiates Coverage of Onxeo with a “Buy” Recommendation	27/05/20	GL
Onxeo : Bryan Garnier & Co Initiates the Coverage of Onxeo with a “Buy” Recommendation	27/05/20	BU

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.113 EUR

Average target price

1.2 EUR

Spread / Average Target

+961.95%

High Price Target

1.2 EUR

Spread / Highest target

+961.95%

Low Price Target

1.2 EUR

Spread / Lowest Target

+961.95%

Consensus detail

Consensus revision (last 18 months)

Annual profits - Rate of surprise

Company calendar